Quick verdict: BTI vs MO in 2026

Overall, Altria Group (MO) appears to hold a slight edge across several key profitability and valuation metrics, despite British American Tobacco (BTI) showing a more compelling DCF valuation and slightly better revenue growth trend. MO leads on key margin indicators and free cash flow generation, suggesting operational efficiency. Analysts, however, show a slightly higher ‘Buy’ percentage for BTI, although MO offers positive implied price target upside. Not investment advice.

BTI vs MO: key metrics side by side

Full side-by-side comparison of BTI and MO across valuation, profitability, growth and analyst sentiment. Data updated 2026-05-07.

BTI vs MO valuation comparison

Comparing the BTI vs MO valuation for 2026 reveals some interesting discrepancies. British American Tobacco (BTI) currently trades at a P/E ratio of 12.07x, which is noticeably lower than Altria Group’s (MO) P/E ratio of 14.42x. This suggests that BTI is perceived as cheaper on an earnings multiple basis, offering a more attractive entry point for investors focused on current earnings. When we look at the price-to-book (P/B) ratio, BTI stands at 1.95x, a more conventional figure often used to assess how much investors are willing to pay for each dollar of a company’s book value. In contrast, MO presents a significantly unusual P/B ratio of -36.15x. While a negative P/B can indicate various financial complexities, such as accumulated losses exceeding equity or aggressive share buybacks, on a purely numerical comparative basis as highlighted in the scorecard, it makes MO appear to have a significantly lower valuation on this metric.

Further delving into the BTI vs MO fundamentals and valuation, the Discounted Cash Flow (DCF) analysis provides a stark contrast in potential upside. BTI shows a remarkable DCF upside of +255.8%, implying a fair value significantly above its current price of $58.375, with a DCF estimate of $207.67. This suggests that, according to the DCF model, BTI is deeply undervalued and holds substantial long-term appreciation potential. Altria (MO), while also indicating an undervaluation, has a more modest DCF upside of +60.0%, with its current price of $69.39 compared to a DCF estimate of $111.04. From a pure intrinsic valuation perspective, BTI appears to be the cheaper stock with substantially higher implied upside according to the DCF model, despite MO showing a numerically lower P/B in absolute terms (albeit negative).

BTI vs MO growth comparison

In terms of growth, both British American Tobacco (BTI) and Altria Group (MO) are navigating a challenging industry landscape, as reflected in their revenue growth figures for 2026. BTI reported a year-over-year revenue growth of -1.0%, indicating a slight contraction in its top line. Altria Group (MO) experienced a revenue growth of -1.5% over the same period. While both companies are seeing a decline in revenue, BTI demonstrates slightly stronger momentum by exhibiting a less severe revenue contraction. This marginal difference suggests BTI might be managing industry headwinds with slightly greater resilience or benefiting from its diverse global market presence compared to MO’s primary focus on the U.S. market. As no specific forward estimates were provided, our analysis relies on the trailing twelve-month data.

While explicit forward revenue estimates are not provided for either BTI or MO stock comparison 2026, the trailing twelve-month revenue figures show BTI with a larger revenue base of $25.61B compared to MO’s $20.14B. The slightly better revenue trend for BTI, even if still negative, could be interpreted as a sign of relative strength in adapting to evolving consumer preferences or regulatory changes within the tobacco sector. For investors analyzing BTI vs MO fundamentals and valuation, this slight lead in revenue performance indicates BTI has stronger momentum in mitigating revenue declines as of 2026. However, it’s crucial to acknowledge that both companies face an overarching trend of decreasing traditional tobacco product consumption, and true growth remains a significant challenge for the sector as a whole.

BTI vs MO profitability

When assessing BTI vs MO profitability, Altria Group (MO) demonstrates a clear advantage across several key metrics. MO boasts a net margin of 36.91%, significantly higher than BTI’s net margin of 30.23%. This indicates that Altria is more efficient at converting its revenue into net income, retaining a larger portion of each dollar earned after all expenses and taxes. Furthermore, MO’s EBITDA margin of 53.61% also surpasses BTI’s 48.99%, reinforcing Altria’s superior operational efficiency before accounting for non-operating expenses like interest, taxes, depreciation, and amortization. These margin differentials highlight MO’s stronger command over its cost structure and pricing power.

In terms of cash generation, MO also leads with a Free Cash Flow (FCF) yield of 7.44%, which is substantially higher than BTI’s 4.7%. A higher FCF yield suggests that MO is generating more cash relative to its market capitalization, which is a strong indicator of financial health and ability to fund dividends, share buybacks, or debt reduction without relying on external financing. While Return on Equity (ROE) is not available for either company, making a direct comparison impossible on that front, the available data consistently and strongly points to Altria Group as the more profitable entity between BTI and MO, consistently generating higher margins and a superior free cash flow yield from its operations.

Analyst ratings: BTI vs MO

The analyst ratings provide a nuanced perspective when comparing BTI vs MO stock comparison 2026. For British American Tobacco (BTI), a total of 18 analysts cover the stock, with a robust 66.7% recommending a “Buy.” The consensus rating for BTI is “Buy,” indicating a generally positive sentiment towards the company’s prospects among the analyst community. However, the average analyst price target stands at $40, implying a significant downside of -31.5% from its current price of $58.375. This divergence between a high buy rating percentage and a negative price target suggests that while analysts might view BTI’s long-term prospects or underlying business favorably, its current market price may be considered overvalued relative to their short-to-medium-term price expectations.

For Altria Group (MO), a larger pool of 26 analysts tracks the company, with 61.5% recommending a “Buy,” also leading to a “Buy” consensus. This still represents a strong positive sentiment, though slightly lower than BTI’s percentage. Unlike BTI, MO’s average analyst price target of $71.67 implies a positive, albeit modest, upside of +3.3% from its current price of $69.39. While BTI has a slightly higher percentage of ‘Buy’ ratings, MO’s analyst target is more aligned with a positive immediate investment outlook, suggesting modest appreciation potential. This makes MO appear to be the preferred choice for analysts seeking immediate positive price movement, despite BTI receiving a numerically stronger ‘Buy’ signal in terms of percentage.

Should I buy BTI or MO stock in 2026?

When considering whether should I buy BTI or MO stock in 2026, growth investors might lean slightly towards BTI due to its marginally less negative year-over-year revenue growth of -1.0% compared to MO’s -1.5%. While both are experiencing declines in top-line revenue, BTI’s larger revenue base ($25.61B vs $20.14B) combined with this relative performance could suggest a better positioned company to stabilize or potentially pivot towards new growth avenues in the evolving tobacco and nicotine industry. However, neither stock presents a compelling growth narrative in traditional terms, given the industry’s significant headwinds and shift away from conventional products.

For value investors primarily focused on BTI vs MO fundamentals and valuation, British American Tobacco (BTI) stands out significantly. Its P/E ratio of 12.07x is lower than MO’s 14.42x, indicating a cheaper valuation relative to earnings. More strikingly, BTI’s DCF analysis suggests an enormous upside of +255.8%, projecting a fair value of $207.67, far exceeding MO’s respectable but smaller +60.0% DCF upside. This suggests BTI might be substantially undervalued according to this intrinsic valuation method, offering a potentially higher margin of safety and long-term capital appreciation, assuming the market eventually aligns with its intrinsic value. MO’s negative P/B ratio introduces complexities for direct comparison on this metric, but its higher P/E is generally less attractive for a pure value play.

Income investors, traditionally drawn to the tobacco sector, will find little to differentiate BTI and MO on current dividend yield alone, as both companies offer an identical dividend yield of 0.06%. This unusually low figure for the sector suggests either recent data changes or specific company policies that current yield reflects. However, MO’s superior FCF yield of 7.44% compared to BTI’s 4.7% indicates that Altria generates significantly more free cash flow relative to its market cap. This robust cash generation could support higher or more sustainable dividend payouts in the future, even if the current reported yield is identical. Investors should research historical dividend policies closely beyond this immediate snapshot to fully understand each company’s commitment to shareholder returns. This is not investment advice; always conduct your own thorough due diligence and consult with a financial professional.

More BTI and MO comparisons

BTI full stock analysis · MO full stock analysis · All stock comparisons

FAQ: BTI vs MO